Dr. Hao Zheng | Pharmacology | Best Academic Researcher Award

Posted on by ScienceFather

Dr. Hao Zheng | Pharmacology | Best Academic Researcher Award

Dr. Hao Zheng | Pharmacology | University of Macau | China

Dr. Hao Zheng is an emerging leader in biomedical sciences with expertise in cancer pharmacology, metabolic disorders, chemical biology, and natural product therapeutics, currently pursuing his Ph.D. in Biomedical Sciences (Pharmacology of Metabolic Disorders) at the University of Macau after completing a B.S. in Chinese Materia Medica at Shandong University of Traditional Chinese Medicine and a Master’s in Pharmacy (Tumor Pharmacology) at Shandong University. His professional experience includes intensive research at the Key Laboratory of Natural Product Chemical Biology under Prof. Ren Dongmei, focusing on anti-tumor, antioxidant, anti-inflammatory, and neuroprotective natural compounds, as well as at the State Key Laboratory of Quality Research in Traditional Chinese Medicine, where he contributed to projects on diabetes pathogenesis, glucose metabolism, insulin resistance, and metabolic disorders. Dr. Zheng’s research interests center on mechanistic studies of ER-stress-mediated apoptosis, ROS-ER-stress pathways, autophagy, methuosis, PDEδ-KRAS interactions, and bioactive compound screening, integrating cellular assays, molecular biology, and pharmacological evaluation. He has successfully led multiple projects investigating natural compounds’ anti-cancer effects, including Epimedokoreanin B, (12R/12S)-Cantleyanone D, Gaudichadion H, and their mechanisms in lung and pancreatic cancer cells, while also contributing to metabolic disorder research such as glucose uptake modulation, mitochondrial pathways, and the role of LARS2 in insulin resistance. Dr. Zheng has authored 7 peer-reviewed publications, cited 123 times with an h-index of 6, demonstrating his impact on the scientific community. He has actively participated in academic forums and international symposiums, receiving recognition for innovation and service, and continues to mentor junior researchers while fostering collaborations across disciplines. His professional skills include experimental pharmacology, natural product chemistry, metabolic pathway analysis, bioassays, and mechanistic pharmacology, supported by strong analytical and problem-solving capabilities.

Professional Profile: Scopus

Selected Publications 

  1. Zheng, H., et al. (2025). Garcioligantone J and K, a pair of epimeric caged-polyprenylated xanthonoids from Garcinia Oligantha, inhibit the growth of lung cancer cells through ER stress-mediated apoptosis. Pharmaceutical Science Advances, 2 citations.

  2. Zheng, H., et al. (2024). Epimedokoreanin B inhibits proliferation of lung cancer cells by inducing ER-stress-mediated paraptosis and autophagosome accumulation. Journal of Natural Products, 5 citations.

  3. Zheng, H., et al. (2023). (12R/12S)-Cantleyanone D induces apoptosis in lung cancer cells through the ROS-ER-stress pathway. Phytochemistry Letters, 4 citations.

  4. Zheng, H., et al. (2023). Gaudichadion H inhibits KRAS mutant pancreatic cancer growth via PDEδ-KRAS interaction interference. Bioorganic & Medicinal Chemistry Letters, 6 citations.

  5. Zheng, H., et al. (2022). Lactucin promotes glucose uptake and glycolysis in C2C12 myotubes through the AMPK-GLUT4 pathway. Journal of Ethnopharmacology, 3 citations.

Dr. Wanderimam Tuktur | Medical | Best Researcher Award

Posted on by ScienceFather

Dr. Wanderimam Tuktur | Medical | Best Researcher Award

Dr. Wanderimam Tuktur | Medical | DC Department of Health | United States

Dr. Wanderimam R. Tuktur, MBBS, MPH, PhD, is an accomplished and analytical public health professional with over twelve years of diverse experience in epidemiological research, geospatial analysis, health equity, and community-focused health interventions. Currently serving as a Public Health Analyst at the District of Columbia Department of Health, Office of Health Equity, he is dedicated to addressing the root causes of health disparities and advancing data-driven policies that promote equitable health outcomes for all communities. Dr. Tuktur’s professional journey reflects a seamless integration of clinical expertise and public health research, having previously held roles as an Epidemiologist at the Virginia Department of Health, a Research Analyst at Capital Area Health Network, and a Research Associate at Virginia Commonwealth University. His research and analytical proficiency span a wide spectrum, including predictive modeling, GIS-based health mapping, and the development of innovative tools like the DC Health Opportunity Index—an evidence-based framework for understanding social determinants of health.

Professional Profile

ORCID

Suitability Summary

Dr. Wanderimam R. Tuktur is exceptionally well-qualified for the Best Researcher Award, standing out as a seasoned and analytical public health professional with over 12 years of diverse experience spanning epidemiological research, geospatial analysis, health equity studies, and quantitative/qualitative data analytics. His multidisciplinary expertise bridges medicine, data science, and public health, demonstrating excellence in both applied research and community-focused interventions.

Education

  • Doctorate Degree in Public Health (Epidemiology) – Walden University, 2024

  • Master of Public Health (Global Health) – Liberty University, 2017

  • Bachelor of Medicine, Bachelor of Surgery (MBBS) – Ahmadu Bello University, 2012

Professional Experience

  • Public Health Analyst | District of Columbia Department of Health, Office of Health Equity (2022 – Present)
    Leads data-driven projects and research to address social determinants of health and health disparities. Oversees the DC Health Opportunity Index development, manages equity programs such as the Advancing Health Literacy Project (AHLP), and supports multi-sector collaborations aimed at improving population health outcomes and advancing health equity in Washington, D.C.

  • Epidemiologist | Virginia Department of Health, Office of Health Equity (2021 – 2022)
    Applied epidemiological and geospatial methods to identify health disparities, performed predictive modeling, and guided public health policy through data-informed recommendations for improving healthcare access across Virginia.

  • Data/Research Analyst | Capital Area Health Network (2021 – 2022)
    Ensured integrity of clinical and financial data systems, analyzed data for accurate reporting to HRSA, and trained staff in health information management software.

  • Research Analyst | Capital Area Analytica Inc. (capAHEC Data Center) (2018 – 2021)
    Conducted predictive modeling on healthcare disparities, managed large datasets, and generated insights for public health policies aimed at underserved communities.

  • Research Associate | Virginia Commonwealth University, Department of Family Medicine & Population Health (2017 – 2018)
    Contributed to a longitudinal cohort study on stress and social disparities in diabetes, managed community-based research partnerships, and supported manuscript preparation for publication.

  • Teaching Instructor | Liberty University, School of General Studies (2015 – 2016)
    Delivered undergraduate instruction, developed course materials, and provided academic mentorship to enhance student learning outcomes.

  • Teaching Assistant | Liberty University, Department of Public & Community Health (2016 – 2017)
    Supervised student projects, supported professors in course delivery, and participated in simulation-based teaching sessions.

  • Medical Officer | National Assembly Clinic & National Hospital, Abuja, Nigeria (2013 – 2015)
    Delivered inpatient and outpatient care, performed clinical evaluations, and participated in rotations across Surgery, Medicine, Pediatrics, and Obstetrics & Gynecology.

Achievements

  • Led the creation of the DC Health Opportunity Index, a comprehensive data visualization tool mapping health inequities and social determinants across Washington, D.C.

  • Directed the Advancing Health Literacy Project (AHLP), resulting in a model toolkit and curriculum for community-based organizations.

  • Provided epidemiological and analytic leadership in multiple CDC-funded Health Disparities Grants, improving COVID-19 vaccine outreach and equity strategies.

  • Developed predictive geospatial models to identify High Priority Health Target Areas in Virginia, influencing healthcare access and policy designations.

  • Published reports and guided evidence-based policymaking to address health disparities in marginalized populations.

Awards and Honors

  • Certificate of Practicing License as a General Practitioner

  • Certificate of Completion – Collaborative Institutional Training Initiative (CITI) in Responsible Conduct of Research (RCR) and Human Subjects Research (HSR), Liberty University

  • Program Evaluation Training Certification, Ahmadu Bello University

  • Sphere Training Certification on Humanitarian and Disaster Relief

  • Virginia Commonwealth University Medication Management Training

  • American Red Cross First Aid and CPR Certification

  • Guest Lectureship Recognition, Liberty University (2015–2017)

Professional Memberships and Affiliations:

  • Active Member, Rotary Club of Richmond, Virginia

  • Member, Academy of Nutrition and Dietetics

  • Member, American Public Health Association

Publication Top Notes

A Geographic Weighted Regression Analysis of the Health Opportunity Index and Stroke Prevalence in Health and Human Services Region 3
Metachronous Malignancy (Pancreatic Endocrine Neoplasm And Renal Cell Carcinoma): Case Report.

Assist. Prof. Dr. Jing-Da Qiao | Medicine | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Jing-Da Qiao | Medicine | Best Researcher Award

Assist. Prof. Dr. Jing-Da Qiao, Guangzhou Medical University, China

Jingda Qiao is a dedicated biomedical researcher with a multidisciplinary background in pharmaceutical engineering, neuroscience, and biomedical science. He holds a Bachelor’s degree in Pharmaceutical Engineering from Guangzhou University of Chinese Medicine, a Master’s degree in Neuroscience from Zhongshan School of Medicine at Sun Yat-sen University under the supervision of Prof. Huaiyu Gu, and a Ph.D. in Biomedical Science from The Chinese University of Hong Kong, mentored by Professors Wing-Ho Yung and Ya Ke. Jingda’s research focuses on the pathogenesis and treatment of neurodevelopmental disorders, combining genome-wide sequencing with transgenic animal models such as mice and Drosophila to investigate novel disease-related genes. He is also actively engaged in exploring the mechanisms of learning, memory, and neural plasticity using electrophysiology, live imaging, and behavioral analysis. His technical expertise spans electrophysiology, molecular biology, behavioral neuroscience, and analytical chemistry. Recognized for his academic excellence, Jingda has received prestigious honors including the Guangdong Overseas Postdoctoral Fellowship and selection as a Young Talent under Guangzhou’s Senior Ranking Personnel Program.

Professional Profile:

ORCID

🏅 Summary of Suitability for Best Researcher Award 

Dr. Jingda Qiao is a multidisciplinary biomedical scientist with strong academic foundations and hands-on expertise in neuroscience, biomedical science, and analytical chemistry. With advanced training across prestigious institutions in China and Hong Kong, his work bridges molecular, cellular, and behavioral neuroscience—making him a highly suitable candidate for the Best Researcher Award.

🎓 Education

  • 🧪 Bachelor of Engineering
    Major: Pharmaceutical Engineering
    Institution: Guangzhou University of Chinese Medicine

  • 🧠 Master of Science
    Major: Neuroscience
    Institution: Zhongshan School of Medicine, Sun Yat-sen University
    Supervisor: Prof. Huaiyu Gu

  • 🔬 Doctor of Philosophy (Ph.D.)
    Major: Biomedical Science
    Institution: The Chinese University of Hong Kong
    Supervisors: Prof. Wing-Ho Yung and Prof. Ya Ke

🧪 Research Experience & Skills

  • 🔋 Electrophysiology: Patch clamp (whole-cell), brain slice & in vivo LTP

  • 🧬 Molecular Biology: PCR, Western blot, ELISA, flow cytometry, paraffin sectioning

  • 🧠 Behavioral Studies: Rodent & Drosophila models for seizure, learning, memory

  • ⚗️ Analytical Chemistry: GC-MS, HPLC, TOF-MS, UV-Vis, gel filtration, membrane separation

  • 🔍 Microscopy: Laser scanning confocal & scanning electron microscopy

💡 Research Interests

  1. 🧠 Neurodevelopmental Disorders:

    • Gene identification via trio-based genome-wide sequencing

    • Use of transgenic mice and Drosophila to uncover disease mechanisms

  2. 🧠 Learning & Memory Mechanisms:

    • Applying electrophysiology, live imaging, and behavior analysis

    • Investigating synaptic plasticity and neural circuits involved in cognition

🏅 Honors & Awards

  • 🌍 Guangdong Overseas Postdoc Program
    (广东省海外青年博士后引进计划)

  • 🌟 Guangzhou High-Level Talent – Youth Reserve Talent
    (广州市高层次人才 青年后备人才)

Publication Top Notes:

Investigation of epilepsy-related genes in a Drosophila model

<i>ZFHX3</i> variants cause childhood partial epilepsy and infantile spasms with favourable outcomes

Identification of novel pathogenic genes of childhood epileptic encephalopathies

Heterozygous Variants in KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia Via Haploinsufficiency

The Interaction ofUBR4, LRP1, andOPHN1in Refractory Epilepsy:DrosophilaModel to Investigate the Oligogenic Effect on Epilepsy

Iodine Acetonitrile as a Drinking Water Disinfectant Showed a Potential Toxic Effect on Organism

 

Dr. Anmin Huang | Immune Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Anmin Huang | Immune Oncology | Best Researcher Award

Dr. Anmin Huang, Peking university, China

Anmin Huang is a Ph.D. and M.D. candidate in Gastroenterology and Hepatology at Peking University. His research focuses on cancer immunotherapy, immune-related biomarkers, and hepatocellular carcinoma. He has authored several high-impact publications in leading journals such as ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, and Hepatobiliary Pancreatic Diseases International, covering topics such as immune and ferroptosis-related signatures, tumor immune infiltration, and multifunctional tumor vaccines. Additionally, he has contributed to multiple patents, including innovations in apoptotic biomimetic nanoparticles for tumor immunotherapy and efficient anti-cancer tumor vaccines. His work integrates computational and experimental approaches to advance cancer treatment strategies, reflecting his expertise in translational medicine and biomedical engineering.

Professional Profile:

ORCID

Summary of Suitability for Best Researcher Award – Anmin Huang

Dr. Anmin Huang, a Ph.D./MD candidate at Peking University specializing in Gastroenterology and Hepatology, has demonstrated exceptional research contributions in the fields of cancer immunotherapy, hepatocellular carcinoma, and tumor microenvironment analysis. His groundbreaking publications, innovative patents, and impactful translational research make him a strong candidate for the Best Researcher Award.

🎓 Education & Work Experience

  • Ph.D./MD Candidate | Peking University, Major: Gastroenterology and Hepatology

  • Researcher | Specializing in immunotherapy, cancer biology, and hepatocellular carcinoma

🏆 Achievements

  • Research Publications 📚

    • Published multiple high-impact papers in ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, Hepatobiliary Pancreatic Diseases International, and Engineering

    • Developed immune and ferroptosis-related LncRNA signatures for cancer prognosis

    • Contributed to the study of tumor immune infiltration and immunotherapy response

  • Patents & Innovations 🧪

    • Holder of two utility model patents for laboratory equipment

    • Co-inventor of apoptotic biomimetic nanoparticles for tumor immunotherapy

    • Co-inventor of an anti-cancer tumor vaccine with an innovative preparation method

🎖 Awards & Honors

  • Recognized for cutting-edge research in oncology and immunotherapy

  • Contributions to novel cancer treatment strategies and immune regulation

Publication Top Notes:

Engineered Apoptosis-Bioinspired Nanoparticles Initiate Immune Cascade for Cancer Immunotherapy of Malignant Ascites